Philippe Durieux

CISSOID SA manufactures industrial voltage regulators, oscillators and related electrical equipment. It offers temperature semiconductor solutions, delivering standard products and custom solutions for power management, power conversion and signal conditioning in extreme temperature and harsh environments. The firm's products include enable energy, weight and cost savings in lighter, cooling-free and more compact electronic systems. The company was founded by Pierre Delatte, Demeus Laurent, Vincent Dessard and Denis Flandre in 2000 and is headquartered in Mont-Saint-Guibert, Belgium.

Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium.

GreenWatt SA designs and installs on-site bio-methanization plants. It engages in the provision of renewable energy and recycling solutions for waste bio-methanization cogeneration. The company was founded by Marc-Jean Spiltoir, Patrick Alexandre Thierry Rene van den Broucke, and Therese Marie Wathelet Florence in 2004 and is headquartered in Louvain-la-Neuve, Belgium.

Xylowatt SA designs, develops and builds gasification reactors for energy conversion from biomass and waste products. It offers NOTAR gasification reactor that produces syngas; and expert services. The company’s products convert energy from clean wood waste, contaminated wood, creosoted wood, radionuclides contaminated wood, agro residues, and sewage sludge. Its product is used in CHP and industrial applications. The company was founded in 2001 and it is headquartered in Charleroi, Belgium.

CISSOID SA manufactures industrial voltage regulators, oscillators and related electrical equipment. It offers temperature semiconductor solutions, delivering standard products and custom solutions for power management, power conversion and signal conditioning in extreme temperature and harsh environments. The firm's products include enable energy, weight and cost savings in lighter, cooling-free and more compact electronic systems. The company was founded by Pierre Delatte, Demeus Laurent, Vincent Dessard and Denis Flandre in 2000 and is headquartered in Mont-Saint-Guibert, Belgium.

CISSOID SA manufactures industrial voltage regulators, oscillators and related electrical equipment. It offers temperature semiconductor solutions, delivering standard products and custom solutions for power management, power conversion and signal conditioning in extreme temperature and harsh environments. The firm's products include enable energy, weight and cost savings in lighter, cooling-free and more compact electronic systems. The company was founded by Pierre Delatte, Demeus Laurent, Vincent Dessard and Denis Flandre in 2000 and is headquartered in Mont-Saint-Guibert, Belgium.

Sopartec SA is the investment and technology valorization arm of Université Catholique de Louvain (UCL) and was founded in 1942. Sopartec SA is headquartered in Louvain-la-Neuve, Belgium.

Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium.

Xylowatt SA designs, develops and builds gasification reactors for energy conversion from biomass and waste products. It offers NOTAR gasification reactor that produces syngas; and expert services. The company’s products convert energy from clean wood waste, contaminated wood, creosoted wood, radionuclides contaminated wood, agro residues, and sewage sludge. Its product is used in CHP and industrial applications. The company was founded in 2001 and it is headquartered in Charleroi, Belgium.

GreenWatt SA designs and installs on-site bio-methanization plants. It engages in the provision of renewable energy and recycling solutions for waste bio-methanization cogeneration. The company was founded by Marc-Jean Spiltoir, Patrick Alexandre Thierry Rene van den Broucke, and Therese Marie Wathelet Florence in 2004 and is headquartered in Louvain-la-Neuve, Belgium.

Xylowatt SA designs, develops and builds gasification reactors for energy conversion from biomass and waste products. It offers NOTAR gasification reactor that produces syngas; and expert services. The company’s products convert energy from clean wood waste, contaminated wood, creosoted wood, radionuclides contaminated wood, agro residues, and sewage sludge. Its product is used in CHP and industrial applications. The company was founded in 2001 and it is headquartered in Charleroi, Belgium.

Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium.

Sopartec SA is the investment and technology valorization arm of Université Catholique de Louvain (UCL) and was founded in 1942. Sopartec SA is headquartered in Louvain-la-Neuve, Belgium.

Xylowatt SA designs, develops and builds gasification reactors for energy conversion from biomass and waste products. It offers NOTAR gasification reactor that produces syngas; and expert services. The company’s products convert energy from clean wood waste, contaminated wood, creosoted wood, radionuclides contaminated wood, agro residues, and sewage sludge. Its product is used in CHP and industrial applications. The company was founded in 2001 and it is headquartered in Charleroi, Belgium.

Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium.

Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium.

Xylowatt SA designs, develops and builds gasification reactors for energy conversion from biomass and waste products. It offers NOTAR gasification reactor that produces syngas; and expert services. The company’s products convert energy from clean wood waste, contaminated wood, creosoted wood, radionuclides contaminated wood, agro residues, and sewage sludge. Its product is used in CHP and industrial applications. The company was founded in 2001 and it is headquartered in Charleroi, Belgium.

GreenWatt SA designs and installs on-site bio-methanization plants. It engages in the provision of renewable energy and recycling solutions for waste bio-methanization cogeneration. The company was founded by Marc-Jean Spiltoir, Patrick Alexandre Thierry Rene van den Broucke, and Therese Marie Wathelet Florence in 2004 and is headquartered in Louvain-la-Neuve, Belgium.

CISSOID SA manufactures industrial voltage regulators, oscillators and related electrical equipment. It offers temperature semiconductor solutions, delivering standard products and custom solutions for power management, power conversion and signal conditioning in extreme temperature and harsh environments. The firm's products include enable energy, weight and cost savings in lighter, cooling-free and more compact electronic systems. The company was founded by Pierre Delatte, Demeus Laurent, Vincent Dessard and Denis Flandre in 2000 and is headquartered in Mont-Saint-Guibert, Belgium.

Xylowatt SA designs, develops and builds gasification reactors for energy conversion from biomass and waste products. It offers NOTAR gasification reactor that produces syngas; and expert services. The company’s products convert energy from clean wood waste, contaminated wood, creosoted wood, radionuclides contaminated wood, agro residues, and sewage sludge. Its product is used in CHP and industrial applications. The company was founded in 2001 and it is headquartered in Charleroi, Belgium.

GreenWatt SA designs and installs on-site bio-methanization plants. It engages in the provision of renewable energy and recycling solutions for waste bio-methanization cogeneration. The company was founded by Marc-Jean Spiltoir, Patrick Alexandre Thierry Rene van den Broucke, and Therese Marie Wathelet Florence in 2004 and is headquartered in Louvain-la-Neuve, Belgium.

Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium.

Sopartec SA is the investment and technology valorization arm of Université Catholique de Louvain (UCL) and was founded in 1942. Sopartec SA is headquartered in Louvain-la-Neuve, Belgium.

Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium.

Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium.

CISSOID SA manufactures industrial voltage regulators, oscillators and related electrical equipment. It offers temperature semiconductor solutions, delivering standard products and custom solutions for power management, power conversion and signal conditioning in extreme temperature and harsh environments. The firm's products include enable energy, weight and cost savings in lighter, cooling-free and more compact electronic systems. The company was founded by Pierre Delatte, Demeus Laurent, Vincent Dessard and Denis Flandre in 2000 and is headquartered in Mont-Saint-Guibert, Belgium.

CISSOID SA manufactures industrial voltage regulators, oscillators and related electrical equipment. It offers temperature semiconductor solutions, delivering standard products and custom solutions for power management, power conversion and signal conditioning in extreme temperature and harsh environments. The firm's products include enable energy, weight and cost savings in lighter, cooling-free and more compact electronic systems. The company was founded by Pierre Delatte, Demeus Laurent, Vincent Dessard and Denis Flandre in 2000 and is headquartered in Mont-Saint-Guibert, Belgium.

Xylowatt SA designs, develops and builds gasification reactors for energy conversion from biomass and waste products. It offers NOTAR gasification reactor that produces syngas; and expert services. The company’s products convert energy from clean wood waste, contaminated wood, creosoted wood, radionuclides contaminated wood, agro residues, and sewage sludge. Its product is used in CHP and industrial applications. The company was founded in 2001 and it is headquartered in Charleroi, Belgium.

Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium.

Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium.